Search

Search Constraints

You searched for: Author/Creator Bashir, Qaiser

Search Results

11. Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial. Issue 5 (May 2019)

12. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning. Issue 14 (21st March 2017)

13. Double epigenetic modulation of high‐dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor‐risk relapsed lymphoma. Issue 17 (20th May 2016)

14. Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial. Issue 11 (November 2018)

15. Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome. Issue 10 (20th January 2021)

16. Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study. (4th October 2017)

17. Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation. Issue 12 (21st October 2019)

18. Haploidentical transplants for patients with graft failure after the first allograft. Issue 10 (21st July 2020)

20. High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan. Issue 6 (June 2017)